1 March 2023 | ACCESS Guiding Principles V4 - March 2023
| Barr, S; Burningham, K; Golding, S; et al. |
28 February 2020 | An adaptable implementation package targeting evidence-based indicators in primary care: A pragmatic cluster-randomised evaluation
| Willis, TA; Collinson, M; Glidewell, L; et al. |
9 June 2017 | Addressing socio-economic and ethical considerations in biotechnology governance: the potential of a new politics of care
| Wickson, F; Preston, CJ; Binimelis, R; et al. |
1 July 2017 | Against the tide of depoliticisation: The politics of research governance
| Hartley, S; Pearce, W; Taylor, A |
27 October 2014 | The Challenges of Consulting the Public on Science Policy: Examining the Development of European Risk Assessment Policy for Genetically Modified Animals
| Hartley, S; Millar, KM |
20 November 2023 | The Circular Economy in European Union Policy: Explaining an idea's success through policy learning
| Pinyol Alberich, J; Hartley, S |
18 December 2020 | Core commitments for field trials of gene drive organisms
| Long, KC; Alphey, L; Annas, GJ; et al. |
30 March 2020 | Developing and evaluating packages to support implementation of quality indicators in general practice: the ASPIRE research programme, including two cluster RCTs
| Foy, R; Willis, T; Glidewell, L; et al. |
24 February 2023 | Engagement on risk assessment for gene drive mosquitoes by EFSA and Target Malaria
| Hartley, S; Kokotovich, A; Devos, Y; et al. |
4 May 2016 | Essential Features of Responsible Governance of Agricultural Biotechnology
| Hartley, S; Gillund, F; van Hove, L; et al. |
25 March 2019 | The ethics of genome editing in non-human animals: A systematic review of reasons reported in the academic literature
| de Graeff, N; Jongsma, KR; Johnston, J; et al. |
1 September 2017 | European Novel Foods Policy at a Critical Juncture:
Drawing lessons for future Novel Food Governance
through a retrospective examination of Regulation 258/97
| Hyde, R; Hartley, S; Millar, K |
21 March 2021 | Experimenting with co-development: a qualitative study of gene drive research for malaria control in Mali
| Hartley, S; Ledingham, K; Owen, R; et al. |
25 January 2022 | Gene drives in the U.K., U.S., and Australian press (2015-2019): How a new focus on responsibility is shaping science communication
| Stelmach, A; Nerlich, B; Hartley, S |
25 April 2019 | Guidance on stakeholder engagement practices to inform the development of areawide vector control methods
| Thizy, D; Emerson, C; Gibbs, J; et al. |
3 July 2019 | Heritable Genome Editing in a Global Context: National and International Policy Challenges
| Rosemann, A; Balen, A; Nerlich, B; et al. |
8 November 2021 | Home-based Extended Rehabilitation for Older people (HERO): study protocol for an individually randomised controlled multi-centre trial to determine the clinical and cost-effectiveness of a home-based exercise intervention for older people with frailty as extended rehabilitation following acute illness or injury, including embedded process evaluation
| Prescott, M; Lilley-Kelly, A; Cundill, B; et al. |
22 March 2018 | Improving the management of pain from advanced cancer in the community: Study protocol for a pragmatic multicentre randomised controlled trial
| Allsop, MJ; Wright-Hughes, A; Black, K; et al. |
11 June 2018 | An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): Study protocol for a cluster randomised controlled feasibility trial
| Forster, A; Hartley, S; Barnard, L; et al. |
15 March 2023 | An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care)
| Forster, A; Ozer, S; Brindle, R; et al. |